Personalized Vaccine Educates Immune System to Fight Brain Tumors
New Signaling Pathway in Brain Tumors Identified
Novel gene therapy boosts survival for those with deadly brain tumor
Watch Jeffrey Raizer, MD: “Why Clinical Trials Matter”
New Results Show Personalized Brain Tumor Vaccine Helps Patients Live Longer
View more news...


Rooftop Cocktail Party for NBTI, Sept. 23
Brain Tumor Patient & Caregiver Forum, Oct. 20
Head for the Cure 5K, Oct. 26
The Northwestern Brain Tumor Institute (NBTI) is a nationally recognized leader in the fight against brain and spinal cord tumors, offering patients the most advanced clinical trial and treatment options available. Our ability to call upon the world-class resources of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, a National Cancer Institute (NCI) - designated Comprehensive Cancer Center, the research and medical expertise of the Northwestern University Feinberg School of Medicine and Northwestern Medical Faculty Foundation, and the preeminent healthcare facilities of Northwestern Memorial Hospital allows the NBTI to provide patients with the best possible care.



Facebook Facebook You Tube